Supporting Health

We go beyond medicine to deliver innovative, holistic health care solutions to patients.

These triplets in Kosovo are among 2,100 babies reached through our donation program that aims to improve prematurity survival rates in that country.

We’re Addressing Local Health Care Challenges

Respiratory diseases among premature babies is a leading cause of infant mortality in many countries and we work with partners to find solutions and raise awareness. One of our global initiatives is made up of 20 coalitions bringing together parent groups, medical and scientific organizations and other multi-disciplinary stakeholders around the world. Our aim is to improve standards of care and access to treatment and support for premature infants.

In the Philippines, we’re partnering with the Philippines Society of Newborn Medicine to reduce prevalence of respiratory distress syndrome (RDS), the second leading cause of infant mortality there. Together we’ve created a national online registry to track disease rates, a crucial first step in controlling RDS.

We’re Increasing Access to Treatment

Through partnerships and licensing agreements, AbbVie is working to improve the lives of individuals living with HIV and HCV. For example:

  • AbbVie and the Medicines Patent Pool signed an agreement in 2014 that will increase access to HIV treatment and improve the lives of children living with the disease.
  • We signed another licensing agreement with Medicines Patent Pool (MPP) in 2015 to address future demands for HIV-1 treatment in South Africa and across Africa.
  • In 2018 we signed our third licensing agreement with MPP, which will allow WHO-qualified generic manufacturers to produce lower-cost versions of our pan-genotypic HCV medicine in more than 90 low- and middle-income countries and territories.
  • Our partnership with HarborPath provides free anti-retroviral medications to uninsured patients in the United States

We’re Improving Patient Treatment Outcomes

It takes a collaborative approach to improve the lives of our patients. Pharmacy Solutions, an AbbVie pharmacy in the United States, is working with health care providers, patients and payers to improve patient treatment outcomes by supporting access to medications, pharmacy services and care management solutions.

Pharmacy Solutions is the first biopharmaceutical company-owned specialty pharmacy to receive accreditation status by the Accreditation Commission for Health Care (ACHC) for the services of Specialty Pharmacy and Durable Medical Equipment Service (DMEPOS) in 2013.

We’re Supporting Industry Patient Assistance Programs

We support the Partnership for Prescription Assistance (PPA). The PPA offers a single point of access to information on 475 public and private patient assistance programs, including nearly 200 programs offered by pharmaceutical companies. Since launch, the PPA has connected nearly 10 million people to patient assistance programs that may meet their needs.